Cargando…

Psychological Impact on Parents of an Inconclusive Diagnosis Following Newborn Bloodspot Screening for Cystic Fibrosis: A Qualitative Study

Genetic results of uncertain clinical significance are being returned to parents following newborn screening, representing a paradigm change in how society considers health and illness. ‘Cystic Fibrosis screen positive, inconclusive diagnosis’ (CFSPID) is a designation given to newborns with a posit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Johnson, Faye, Southern, Kevin W., Ulph, Fiona
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510205/ https://www.ncbi.nlm.nih.gov/pubmed/33072982 http://dx.doi.org/10.3390/ijns5020023

Ejemplares similares

Constructing a Bioethical Framework to Evaluate and Optimise Newborn Bloodspot Screening for Cystic Fibrosis
por: Armstrong, Rachael E., et al.
Publicado: (2020)

Parental Decision-Making and Acceptance of Newborn Bloodspot Screening: An Exploratory Study
por: Nicholls, Stuart G., et al.
Publicado: (2013)

Qualitative exploration of health professionals’ experiences of communicating positive newborn bloodspot screening results for nine conditions in England
por: Chudleigh, Jane, et al.
Publicado: (2020)

Inconclusive Diagnosis after Newborn Screening for Cystic Fibrosis
por: Munck, Anne
Publicado: (2020)

Understanding Midwives’ Preferences for Providing Information About Newborn Bloodspot Screening
por: Wright, Stuart James, et al.
Publicado: (2018)

Process evaluation of co-designed interventions to improve communication of positive newborn bloodspot screening results
por: Chudleigh, Jane, et al.
Publicado: (2021)

The Role of Information Provision in Economic Evaluations of Newborn Bloodspot Screening: A Systematic Review
por: Wright, Stuart J., et al.
Publicado: (2015)

Cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID)
por: Sinha, Aditi, et al.
Publicado: (2021)

Immunoreactive trypsinogen levels in newborn screened infants with an inconclusive diagnosis of cystic fibrosis
por: Ooi, Chee Y., et al.
Publicado: (2019)

Co-designing Improved Communication of Newborn Bloodspot Screening Results to Parents: Mixed Methods Study
por: Chudleigh, Jane, et al.
Publicado: (2022)

International Approaches to Management of CFTR-Related Metabolic Syndrome/Cystic Fibrosis Screen Positive, Inconclusive Diagnosis
por: Chudleigh, Jane, et al.
Publicado: (2022)

Parents’ views on accepting, declining, and expanding newborn bloodspot screening
por: van der Pal, Sylvia M., et al.
Publicado: (2022)

Parents' responses to receiving sickle cell or cystic fibrosis carrier results for their child following newborn screening
por: Ulph, Fiona, et al.
Publicado: (2015)

Cystic Fibrosis Screen Positive, Inconclusive Diagnosis Genotypes in the Cystic Fibrosis Registry
por: Thompson, Cassandra, et al.
Publicado: (2023)

Processing Newborn Bloodspot Screening Results for CF
por: Barben, Jürg, et al.
Publicado: (2020)

Newborn bloodspot screening in the time of COVID-19
por: Greaves, Ronda F., et al.
Publicado: (2021)

Receiving results of uncertain clinical relevance from population genetic screening: systematic review & meta-synthesis of qualitative research
por: Johnson, Faye, et al.
Publicado: (2022)

Parental Depression and Anxiety Associated with Newborn Bloodspot Screening for Rare and Variable-Onset Disorders
por: Boychuk, Natalie A., et al.
Publicado: (2022)

Why Do We Screen Newborn Infants for Cystic Fibrosis?
por: Barben, Jürg, et al.
Publicado: (2020)

A Multicentre Italian Study on the Psychological Impact of an Inconclusive Cystic Fibrosis Diagnosis after Positive Neonatal Screening
por: Tosco, Antonella, et al.
Publicado: (2023)

Imparting carrier status results detected by universal newborn screening for sickle cell and cystic fibrosis in England: a qualitative study of current practice and policy challenges
por: Parker, Hilda, et al.
Publicado: (2007)

Secondary research uses of residual newborn screening dried bloodspots: a scoping review
por: Rothwell, Erin, et al.
Publicado: (2018)

Cystic Fibrosis-Screening Positive Inconclusive Diagnosis: Newborn Screening and Long-Term Follow-Up Permits to Early Identify Patients with CFTR-Related Disorders
por: Castaldo, Alice, et al.
Publicado: (2020)

Parental Awareness, Knowledge, and Attitudes Regarding Current and Future Newborn Bloodspot Screening: The First Report from Thailand
por: Wilaiwongsathien, Kalyarat, et al.
Publicado: (2023)

Outcomes of children with cystic fibrosis screen positive, inconclusive diagnosis/CFTR related metabolic syndrome
por: Gunnett, Mohini A., et al.
Publicado: (2023)

Communicating cystic fibrosis newborn screening results to parents
por: Seddon, L., et al.
Publicado: (2020)

Processing of positive newborn screening results: a qualitative exploration of current practice in England
por: Chudleigh, Jane, et al.
Publicado: (2020)

Comparison between Gibson–Cooke and Macroduct Methods in the Cystic Fibrosis Neonatal Screening Program and in Subjects Who Are Cystic Fibrosis Screen-Positive with an Inconclusive Diagnosis
por: Dolce, Daniela, et al.
Publicado: (2023)

Pseudo‐Bartter syndrome in infant with cystic fibrosis screen positive, inconclusive diagnosis: A case report
por: Sepe, Angela, et al.
Publicado: (2023)

Assessing a New Method for Measuring Fetal Exposure to Mercury: Newborn Bloodspots
por: Nelson, Jessica W., et al.
Publicado: (2016)

Rethinking Strategies for Positive Newborn Screening Result (NBS+) Delivery (ReSPoND): a process evaluation of co-designing interventions to minimise impact on parental emotional well-being and stress
por: Chudleigh, Jane, et al.
Publicado: (2019)

Stakeholder attitudes towards the role and application of informed consent for newborn bloodspot screening: a study protocol
por: Nicholls, S G, et al.
Publicado: (2014)

Longitudinal metabolomics in dried bloodspots yields profiles informing newborn screening for succinic semialdehyde dehydrogenase deficiency
por: Brown, Madalyn, et al.
Publicado: (2020)

Newborn Screening for Cystic Fibrosis in Delaware
por: Shenoy, Ambika, et al.
Publicado: (2018)

Impact of newborn screening on outcomes and social inequalities in cystic fibrosis: a UK CF registry-based study
por: Schlüter, Daniela K, et al.
Publicado: (2020)

Impact of Pancreatitis-Associated Protein on Newborn Screening Outcomes and Detection of CFTR-Related Metabolic Syndrome (CRMS)/Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID): A Monocentric Prospective Pilot Experience
por: Bianchimani, Chiara, et al.
Publicado: (2022)

Variability in the storage and use of newborn dried bloodspots in Canada: is it time for national standards?
por: Avard, Denise, et al.
Publicado: (2006)

The Cost-Effectiveness of Expanding the UK Newborn Bloodspot Screening Programme to Include Five Additional Inborn Errors of Metabolism
por: Bessey, Alice, et al.
Publicado: (2020)

Policy-making and implementation for newborn bloodspot screening in Europe: a comparison between EURORDIS principles and UK practice
por: Lombardo, Silvia, et al.
Publicado: (2023)

Cystic fibrosis diagnosed by state newborn screening: Or is it?
por: Fox, Maura, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2qo398fv6e72quhdilvie62735